Blotting Innovations was awarded in September 2022 a Phase I STTR grant from the NIH. This grant is a testament to our commitment and expertise in developing a high-throughput western blot.
At Blotting Innovations, our research and development efforts are not only focused on innovation but also on making our products accessible. Our 96-well pre-cast gels and horizontal electrophoresis tanks, designed to accommodate these gels, are competitively priced, making them a cost-effective alternative to standard Western blotting techniques. We aim to reassure scientists that our products are not only innovative but also affordable.